Deutsch English Français

Contact

EP0978568

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP0978568

EP0978568 - Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 05.08.2005 Database last updated on 06.07.2024
Most recent event Tooltip	14.03.2008	Lapse of the patent in a contracting state New state(s): LU, PT	published on 16.04.2008 [2008/16]
Applicant(s)	For all designated states BAYER CORPORATION 100 Bayer Road Pittsburgh, PA 15205-9741 / US
	[N/P]
Former [2000/06]	For all designated states Bayer Corporation 100 Bayer Road Pittsburgh, PA 15205-9741 / US
Inventor(s)	01 / Cast, Todd K. 52161 Woodsedge Drive Granger, Indiana / US
	02 / Pugia, Michael J. 14342 Taddington Drive Granger, Indiana 46530 / US
	[2000/06]
Representative(s)	Burkert, Frank, et al Bayer Schering Pharma Aktiengesellschaft Law and Patents Patents and Licensing Building Q 18 51368 Leverkusen / DE
	[N/P]
Former [2000/06]	Burkert, Frank, et al Bayer AG, Konzernbereich RP Patente und Lizenzen 51368 Leverkusen / DE
Application number, filing date	99114166.4	21.07.1999
	[2000/06]
Priority number, date	US19980128009	03.08.1998 Original published format: US 128009
	[2000/06]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP0978568
	Date:	09.02.2000
	Language:	EN
	[2000/06]
	Type:	A3 Search report
	No.:	EP0978568
	Date:	15.03.2000
	[2000/11]
	Type:	B1 Patent specification
	No.:	EP0978568
	Date:	29.09.2004
	Language:	EN
	[2004/40]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	02.02.2000
Classification	IPC:	C12Q1/28, G01N33/70, G01N33/72	[2000/06]
	CPC:	C12Q1/28 (EP,US); G01N33/70 (EP,US); G01N33/72 (EP,US); Y10T436/14 (EP,US); Y10T436/147777 (EP,US); Y10T436/206664 (EP,US); (+) Y10T436/25125 (EP,US) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2004/44]
Former [2004/39]	BE, CH, DE, ES, FI, FR, GB, IE, IT, LI, NL, SE
Former [2000/06]	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE
Title	German:	Verfahren zur Verhinderung von Hämoglobininterferenzen in Reagenzsystemen die für peroxidase Bestimmung geeignet sind	[2000/06]
	English:	Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity	[2000/06]
	French:	Méthode pour la prévention d'interférence de l'hémoglobine dans les systèmes réactifs pour la mesure de l'activité péroxidasique	[2000/06]
Examination procedure	15.09.2000	Examination requested [2000/46]
	17.06.2003	Despatch of a communication from the examining division (Time limit: M04)
	08.12.2003	Reply to a communication from the examining division
	12.12.2003	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	09.02.2004	Communication of intention to grant the patent
	21.06.2004	Fee for grant paid
	21.06.2004	Fee for publishing/printing paid
Opposition(s)	30.06.2005	No opposition filed within time limit [2005/38]
Request for further processing for:	08.12.2003	Request for further processing filed
	09.12.2003	Full payment received (date of receipt of payment) Request granted
	14.01.2004	Decision despatched
Fees paid	Renewal fee
	25.07.2001	Renewal fee patent year 03
	22.07.2002	Renewal fee patent year 04
	23.07.2003	Renewal fee patent year 05
	22.07.2004	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	29.09.2004
	BE	29.09.2004
	CH	29.09.2004
	ES	29.09.2004
	LI	29.09.2004
	LU	29.09.2004
	NL	29.09.2004
	GR	29.12.2004
	PT	28.02.2005
	[2008/16]
Former [2007/18]	AT	29.09.2004
	BE	29.09.2004
	CH	29.09.2004
	ES	29.09.2004
	LI	29.09.2004
	NL	29.09.2004
	GR	29.12.2004
Former [2006/14]	AT	29.09.2004
	BE	29.09.2004
	CH	29.09.2004
	LI	29.09.2004
	NL	29.09.2004
	GR	29.12.2004
Former [2005/28]	AT	29.09.2004
	BE	29.09.2004
	CH	29.09.2004
	LI	29.09.2004
	GR	29.12.2004
Former [2005/25]	AT	29.09.2004
	CH	29.09.2004
	LI	29.09.2004
	GR	29.12.2004
Former [2005/18]	AT	29.09.2004
	GR	29.12.2004
Former [2005/13]	AT	29.09.2004
Documents cited:	Search	[A]US3630680 (RITTERSDORF WALTER, et al) [A] 1,11 * example 5 *;
		[A]US4069016 (WU TAI-WING) [A] 1,11 * column 9, line 6; table 1 *;
		[A]US4345911 (KOHL HELMUT) [A] 1,11;
		[A]US4562043 (MENNEN FREDERICK C [US], et al) [A] 1,11 * column 7, line 34 - line 38 *;
		[A]EP0281000 (KONISHIROKU PHOTO IND [JP]) [A] 1,11 * page 6, lines 6,40 *;
		[A]US5242832 (SAKATA TAKASHI [JP]) [A] 1,11 * example 7 *;
		[A]US5612223 (KIM YOUNG R [US], et al) [A] 1,11 * claim 1 *;
		[DA]US5702955 (PUGIA MICHAEL [US]) [DA] 1,11* the whole document *;
		[DAP]EP0924521 (BAYER AG [US]) [DAP] 1,11 * the whole document *;
		[A] - EVANS, PATRICIA J. (1) ET AL, "Oxidative damage to lipids and alpha-1-antiproteinase by phenylbutazone in the presence of haem proteins: Protection by ascorbic acid.", BIOCHEMICAL PHARMACOLOGY, (1992) VOL. 44, NO. 5, PP. 981-984., XP000863486 [A] 1,11 DOI: http://dx.doi.org/10.1016/0006-2952(92)90131-2
	Examination	US5374561

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p